Cited by 58NF-κB Signaling PathwaysCell death mechanisms and regulationSignaling Pathways in Disease

NF-κB and Extrinsic Cell Death Pathways – Entwined Do-or-Die Decisions for T cells

Open access
Blanchett, Sam, Boal-Carvalho, Ines, Layzell, Scott, Seddon, Benedict·2021·Trends in Immunology

Abstract

NF-κB signaling is required at multiple stages of T cell development and function. The NF-κB pathway integrates signals from many receptors and involves diverse adapters and kinases. Recent advances demonstrate that kinases controlling NF-κB activation, such as the IKK complex, serve dual independent functions because they also control cell death checkpoints. Survival functions previously attributed to NF-κB are in fact mediated by these upstream kinases by novel mechanisms. This new understanding has led to a refined view of how NF-κB and cell death signaling are interlinked and how they regulate cell fate. We discuss how NF-κB activation and control of cell death signaling by common upstream triggers cooperate to regulate different aspects of T cell development and function.

Integrity signals

Registry

Crossref · 10.1016/j.it.2020.10.013

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The identified TFs (FOXK2 and NR4A1) have important roles in naive CD4+ T cell response upon TCR stimulation.

    “Other studies have also shown that FOXK2 affects the activation of T lymphocytes77,78 and revealed the essential roles of NR4A1 in regulatory T cell differentiation79,80, suggesting that the identified TFs have important roles in naive CD4+ T cell response upon TCR stimulation.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Blanchett, S., Boal-Carvalho, I., Layzell, S., & Seddon, B.
Affiliations
The Royal Free Hospital (GB)
Corresponding author
Seddon, Benedict
Venue
Trends in Immunology
Publisher
Elsevier BV
Published
2021-01
Volume
42
Issue
1
Pages
76-88
ISSN
1471-4906 (ISSN-L)
OpenAlex
W3107859769
Cited by
58
References
3
Citations by year
2026: 7 · 2025: 7 · 2024: 12 · 2023: 11 · 2022: 15 · 2021: 6
FWCI
0.82
Type
journal article
Language
en
Open access
Locations
  • Trends in Immunology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
NF-κB signaling, T cell development, T cell function, IKK complex, cell survival, cell fate regulation, adaptor proteins, kinases
MeSH terms
Animals, Humans, Phosphorylation, T-Lymphocytes, NF-kappa B, Cell Death, I-kappa B Kinase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review